Desiree Deandreis
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications
Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor.
Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor.
Journal: Journal of visceral surgery
Published: August 11, 2026
PET/CT Imaging for Therapy Assessment in Multiple Myeloma Including MRD.
Journal: Cancers
Published: May 22, 2026
New Paradigms in Theranostics of Prostate Cancer: The Rise of α-Emitters and Next-generation Targets.
Journal: European urology focus
Published: May 04, 2026
Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Radiopharmaceutical Therapy Meets Radiobiology: Implications for Trial Design and DNA Repair Inhibitor Combinations.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 30, 2026
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts.
Journal: Oncology and therapy
Published: January 09, 2026
3D-ring CZT gamma cameras in theranostics: is it a revolution?
Journal: EJNMMI reports
Published: January 06, 2026
Challenges and unmet needs of [18F]fluorocholine PET in hyperparathyroidism: A framework for refining current practice and advancing parathyroid imaging.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 05, 2025
Para-aortic lymphadenectomy after negative PET-CT in locally advanced cervical cancer: a continuous monocentric series of 320 cases.
Journal: Gynecologic oncology
Published: December 05, 2025
Molecular Imaging in Parathyroid Carcinoma Management: A Comprehensive Review.
Journal: Life (Basel, Switzerland)
Published: November 07, 2025
[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.
Journal: The Lancet. Oncology
Published: November 04, 2025
Last Updated: 09/26/2026